Our Story

2,000+

Attendees

250

Speakers

130+

Exhibitors

4

Days

THE MOST IMPORTANT ORPHAN DRUG EVENT WORLDWIDE

The World Orphan Drug Congress is an award-winning event with an exhibition that has grown to become the largest and most established orphan drugs & rare diseases meeting of its kind across the globe.

Following a record attendance in 2023 of 1500+ attendees, the World Orphan Drug Congress will be back in October 2024 bringing together the most senior and informed industry experts across the entire orphan drug and rare disease landscape.

We will continue to cover orphan drug progress in:

Cell & Gene Therapy

Gene Testing

Market Access

Epidemiology & Forecasting

Real World Evidence

Global Patient Advocacy

Orphan Drugs Policy

and more

From basic research to commercial manufacture, this one meeting covers the whole orphan drugs value chain where science, government and manufacturers all come together to create ground- breaking progress.

If you are involved in orphan drugs & ATMP, this is the most important meeting you will be part of in 2024.

BOOK MY TICKET

SPONSOR / EXHIBIT NOW

Event Features

WORLD LEADING PRESENTATIONS

Original presentations and updates from the most informed Industry experts across the whole vaccines landscape.

PANEL DEBATES

We have curated panels of 4-5 industry experts to debate some of your burning questions. You’ll be able to watch them live and pose questions directly the panellists.

NETWORKING

With four days’ worth of content, extended breaks and receptions, you will have even more time to meet cross sector contacts with thousands of attendees.

EXHIBITION

Over 3 days you will be able to meet and network with many of the leading solution and service providers helping the vaccine community.

START UP ZONE

The start-up zone will provide a unique environment to meet VCs looking for early stage opportunities as well as companies across pharma, biotech, healthcare, academia, chemicals, food, animal health and the community that serves them.

Join us in OCTOBER for the most up to date and keynote driven content around the pandemic so far!